Xin C et al. |
Sphingosylphosphorylcholine acts in an anti-inflammatory manner in renal mesangial cells by reducing interleukin-1beta-induced prostaglandin E2 formation. |
2007 |
J. Lipid Res. |
pmid:17592175
|
Tobo M et al. |
Previously postulated "ligand-independent" signaling of GPR4 is mediated through proton-sensing mechanisms. |
2007 |
Cell. Signal. |
pmid:17462861
|
Moon HJ et al. |
Sphingosylphosphorylcholine stimulates expression of fibronectin through TGF-beta1-Smad-dependent mechanism in human mesenchymal stem cells. |
2007 |
Int. J. Biochem. Cell Biol. |
pmid:17481939
|
Afrasiabi E et al. |
Antiproliferative effect of sphingosylphosphorylcholine in thyroid FRO cancer cells mediated by cell cycle arrest in the G2/M phase. |
2007 |
Mol. Cell. Endocrinol. |
pmid:17606321
|
Chiulli N et al. |
Sphingosylphosphocholine effects on cultured astrocytes reveal mechanisms potentially involved in neurotoxicity in Niemann-Pick type A disease. |
2007 |
Eur. J. Neurosci. |
pmid:17666077
|
Kwon YB et al. |
Sphingosylphosphorylcholine-induced interleukin-6 production is mediated by protein kinase C and p42/44 extracellular signal-regulated kinase in human dermal fibroblasts. |
2007 |
J. Dermatol. Sci. |
pmid:17321112
|
Kinoshita H et al. |
Sevoflurane, but not propofol, prevents Rho kinase-dependent contraction induced by sphingosylphosphorylcholine in the porcine coronary artery. |
2007 |
Anesth. Analg. |
pmid:17646484
|
Han M et al. |
Effect of direct albumin binding to sphingosylphosphorylcholine in Jurkat T cells. |
2007 |
Prostaglandins Other Lipid Mediat. |
pmid:17991619
|
Kim YS et al. |
The signaling mechanism of the sphingosylphosphorylcholine-induced contraction in cat esophageal smooth muscle cells. |
2007 |
Arch. Pharm. Res. |
pmid:18254249
|
Michel AD and Fonfria E |
Agonist potency at P2X7 receptors is modulated by structurally diverse lipids. |
2007 |
Br. J. Pharmacol. |
pmid:17700717
|
Kishi H et al. |
[Involvement of Fyn tyrosine kinase and membrane rafts in the signal transduction in Ca2+-sensitization of vascular smooth muscle contraction]. |
2007 |
Nippon Yakurigaku Zasshi |
pmid:17435334
|
Xu D et al. |
Involvement of Fyn tyrosine kinase in actin stress fiber formation in fibroblasts. |
2007 |
FEBS Lett. |
pmid:17950286
|
Oh JT et al. |
Quantification of the wound healing using polarization-sensitive optical coherence tomography. |
2006 Jul-Aug |
J Biomed Opt |
pmid:16965152
|
Afrasiabi E et al. |
Sphingosylphosphorylcholine enhances calcium entry in thyroid FRO cells by a mechanism dependent on protein kinase C. |
2006 |
Cell. Signal. |
pmid:16490345
|
Czyborra C et al. |
Indomethacin differentiates the renal effects of sphingosine-1-phosphate and sphingosylphosphorylcholine. |
2006 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:16521006
|
Urs AN et al. |
Sphingosine regulates the transcription of CYP17 by binding to steroidogenic factor-1. |
2006 |
Endocrinology |
pmid:16887917
|
Fujiwaki T et al. |
Quantitative evaluation of sphingolipids using delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to cardiac valves from a patient with Fabry disease. |
2006 |
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. |
pmid:16431168
|
|
Retraction. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. |
2006 |
Nat. Cell Biol. |
pmid:16508674
|
Katayama T et al. |
Blebbistatin inhibits sphingosylphosphorylcholine-induced contraction of collagen-gel fiber populated by vascular smooth-muscle cells. |
2006 |
J. Pharmacol. Sci. |
pmid:17072099
|
Hemmings DG |
Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine. |
2006 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:16570136
|